Common Contracts

Amended and Restated Option Agreement by and between ModernaTx, Inc., and AstraZeneca AB June 15, 2018

Option Agreement • October 9th, 2018 • Moderna, Inc. • Biological products, (no disgnostic substances) • New York

• Contract Type
  Option Agreement
• Filed
  October 9th, 2018
• Company
  Moderna, Inc.
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  New York

This Amended and Restated Option Agreement (this “A&R Option Agreement”) is made on the Amendment Effective Date by and between ModernaTx, Inc., a Delaware corporation (“Moderna”) and AstraZeneca AB, a company incorporated in Sweden under no. 556011-7482 with offices at SE-431 83 Mölndal, Sweden (“AstraZeneca”). Each of Moderna and AstraZeneca may be referred to herein as a “Party” or together as the “Parties.”

Amended and Restated Option Agreement by and between ModernaTx, Inc., and AstraZeneca AB June 15, 2018

Option Agreement • August 30th, 2018 • Moderna, Inc. • Biological products, (no disgnostic substances) • New York

• Contract Type
  Option Agreement
• Filed
  August 30th, 2018
• Company
  Moderna, Inc.
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  New York

This Amended and Restated Option Agreement (this “A&R Option Agreement”) is made on the Amendment Effective Date by and between ModernaTx, Inc., a Delaware corporation (“Moderna”) and AstraZeneca AB, a company incorporated in Sweden under no. 556011-7482 with offices at SE-431 83 Mölndal, Sweden (“AstraZeneca”). Each of Moderna and AstraZeneca may be referred to herein as a “Party” or together as the “Parties.”